Rubicon Point Buys J&J-Leased Campus in Billion-Dollar Strategy

SANTA CLARA, CA – May 14, 2026 – In a powerful signal of confidence in Silicon Valley's specialized real estate market, Rubicon Point Partners has acquired the sprawling Santa Clara headquarters of Shockwave Medical. The four-building, 201,078-square-foot campus, which serves as the R&D nerve center for the Johnson & Johnson subsidiary, marks the first major move in Rubicon Point's ambitious new investment strategy for the West Coast.

The transaction, advised by CBRE National Office Partners, secures a mission-critical asset fully leased to an innovative medical device firm backed by one of the world's most stable corporations. This deal stands in stark contrast to the headwinds facing the broader commercial office market, highlighting a flight to quality and the enduring value of properties anchored in technology and innovation.

A Billion-Dollar Bet on Innovation

The acquisition is the inaugural investment from Rubicon Point Fund II and serves as the cornerstone for a much larger vision. The San Francisco-based firm announced that this is just the beginning of a billion-dollar investment strategy it plans to execute across the West Coast over the next few years.

"This acquisition represents the quality and caliber of assets we will continue to target: mission-critical real estate leased to world-class tenants in the most dynamic markets on the West Coast," said Ani Vartanian, Co-Founder and Managing Partner of Rubicon Point Partners, in a statement. The firm’s thesis-driven approach focuses on identifying high-conviction opportunities in supply-constrained, innovation-fueled markets.

By targeting a property that is not just office space but a vital hub for research and development, Rubicon Point is betting on the tangible output of its tenants. The Shockwave campus is not easily replaceable; it houses the company's executive leadership and its core innovation functions, making it indispensable to the tenant's global operations and future growth.

Silicon Valley's R&D Resilience

While headlines have focused on rising vacancies in general-purpose office towers, specialized R&D and life science campuses in prime locations continue to command premium valuations. The Shockwave property, located on a 12.86-acre site in the heart of Santa Clara, exemplifies this trend. It is situated in an irreplaceable innovation corridor, surrounded by the global headquarters of tech titans like Apple, NVIDIA, and Cisco.

This concentration of talent and technology creates a powerful ecosystem that fuels demand for specialized real estate. Investor appetite remains strong for properties that are integral to a company's core business, particularly in sectors like medical technology. This is further evidenced by other major developments in the area, such as Sutter Health's plan to build out nearly 1 million square feet of new healthcare facilities in Santa Clara, underscoring the region's growth as a hub for both tech and medical innovation.

The market for such properties is characterized by limited supply and high barriers to entry, making existing, well-located campuses like the Shockwave headquarters a highly sought-after asset class. For investors like Rubicon Point, these facilities offer a durable income stream insulated from the volatility affecting more commoditized real estate.

The Johnson & Johnson Factor: Stability in a Turbulent Market

A critical component of the deal's appeal is the strength of its tenant. Shockwave Medical, a pioneer in using intravascular lithotripsy (IVL) to treat calcified cardiovascular disease, was acquired by Johnson & Johnson in a blockbuster $13.1 billion deal completed in May 2024. This acquisition transformed Shockwave into a wholly owned subsidiary of a corporate giant with a AAA credit rating from S&P.

The property is 100% NNN (triple-net) leased to Shockwave, meaning the tenant is responsible for all operating expenses, including property taxes, insurance, and maintenance. This lease structure, combined with the financial fortification provided by Johnson &Johnson, creates an exceptionally secure, low-risk income stream for the property owner.

Shockwave's technology is not just a minor product line; it is a strategic priority for Johnson & Johnson's MedTech division. J&J has stated its intention to build Shockwave into its thirteenth "priority platform," a designation reserved for business lines with at least $1 billion in annual sales. This deep strategic integration ensures a long-term commitment to Shockwave's operations and, by extension, its Santa Clara R&D hub. The acquisition by Rubicon Point is therefore a bet not just on a building, but on the continued success of a leading-edge medical technology that is reshaping cardiovascular treatment.